Coverage
-
March 29, 2022
A New York City investment firm asked a federal judge to let it intervene in a dispute over a $3.8 million international arbitration award against a biotechnology company that reneged on a financing deal, claiming its position as the company's only secured creditor could cost it millions in losses.
6 other articles on this case.
View all »